These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11165874)
1. Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects. Vay D; Parodi M; Rolla R; Mottaran E; Vidali M; Bellomo G; Albano E Free Radic Biol Med; 2001 Feb; 30(3):277-86. PubMed ID: 11165874 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Maggi E; Bellazzi R; Gazo A; Seccia M; Bellomo G Kidney Int; 1994 Sep; 46(3):869-76. PubMed ID: 7996809 [TBL] [Abstract][Full Text] [Related]
3. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Rigamonti C; Mottaran E; Reale E; Rolla R; Cipriani V; Capelli F; Boldorini R; Vidali M; Sartori M; Albano E Hepatology; 2003 Jul; 38(1):42-9. PubMed ID: 12829985 [TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Mottaran E; Stewart SF; Rolla R; Vay D; Cipriani V; Moretti M; Vidali M; Sartori M; Rigamonti C; Day CP; Albano E Free Radic Biol Med; 2002 Jan; 32(1):38-45. PubMed ID: 11755315 [TBL] [Abstract][Full Text] [Related]
5. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation. Seccia M; Albano E; Maggi E; Bellomo G Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648 [TBL] [Abstract][Full Text] [Related]
6. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events. Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443 [TBL] [Abstract][Full Text] [Related]
7. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Palacio JR; Iborra A; Ulcova-Gallova Z; Badia R; Martínez P Clin Exp Immunol; 2006 May; 144(2):217-22. PubMed ID: 16634794 [TBL] [Abstract][Full Text] [Related]
8. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis. Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031 [TBL] [Abstract][Full Text] [Related]
9. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843 [TBL] [Abstract][Full Text] [Related]
10. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. Grönwall C; Amara K; Hardt U; Krishnamurthy A; Steen J; Engström M; Sun M; Ytterberg AJ; Zubarev RA; Scheel-Toellner D; Greenberg JD; Klareskog L; Catrina AI; Malmström V; Silverman GJ J Autoimmun; 2017 Nov; 84():29-45. PubMed ID: 28647488 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids. Rolla R; Vay D; Mottaran E; Parodi M; Vidali M; Sartori M; Rigamonti C; Bellomo G; Albano E Gut; 2001 Dec; 49(6):852-9. PubMed ID: 11709522 [TBL] [Abstract][Full Text] [Related]
12. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis. Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521 [TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530 [TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde. Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571 [TBL] [Abstract][Full Text] [Related]
15. Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds. Thiagarajan D; Frostegård AG; Singh S; Rahman M; Liu A; Vikström M; Leander K; Gigante B; Hellenius ML; Zhang B; Zubarev RA; de Faire U; Lundström SL; Frostegård J J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998914 [TBL] [Abstract][Full Text] [Related]
16. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. Turunen SP; Kummu O; Harila K; Veneskoski M; Soliymani R; Baumann M; Pussinen PJ; Hörkkö S PLoS One; 2012; 7(4):e34910. PubMed ID: 22496875 [TBL] [Abstract][Full Text] [Related]
17. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts. Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction. Vallejo J; Dunér P; Fredrikson GN; Nilsson J; Bengtsson E J Intern Med; 2017 Dec; 282(6):496-507. PubMed ID: 28944562 [TBL] [Abstract][Full Text] [Related]
20. Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans Tatzber F; Pursch E; Resch U; Pfragner R; Holasek S; Lindschinger M; Cvirn G; Wonisch W Oxid Med Cell Longev; 2017; 2017():6047142. PubMed ID: 29250300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]